scholarly article | Q13442814 |
P356 | DOI | 10.1093/ANNONC/MDX759 |
P698 | PubMed publication ID | 29237083 |
P2093 | author name string | T Li | |
K Johnson | |||
D Cella | |||
A Molina | |||
N D Shore | |||
K F Ho | |||
S Traina | |||
P577 | publication date | 2017-12-11 | |
P1433 | published in | Annals of Oncology | Q326122 |
P1476 | title | Relationship between patient-reported outcomes and clinical outcomes in metastatic castration-resistant prostate cancer: post-hoc analysis of COU-AA-301 and COU-AA-302. |
Q90711328 | Bone health management in the continuum of prostate cancer disease: a review of the evidence with an expert panel opinion |
Q90289244 | Cancer symptom response as an oncology clinical trial end point |
Q58565431 | Evaluating methodological quality of Prognostic models Including Patient-reported HeAlth outcomes iN oncologY (EPIPHANY): a systematic review protocol |
Q64118235 | Modeling strategies to improve parameter estimates in prognostic factors analyses with patient-reported outcomes in oncology |
Q91632011 | Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trial |
Q99413028 | Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study |
Q97530805 | The prognostic value of pain in castration-sensitive prostate cancer |
Search more.